In This Section

TME Steering Committee

Theresa A. Guise, MD
Chair

Theresa A. Guise, MD

(2020-2022)

Professor, Endocrine Neoplasia & HD
University of Texas MD Anderson Cancer Center
Co-Director, Rolanette and Berdon Lawrence Bone Disease Program of Texas
Scholar, Cancer Prevention Research Institute of Texas
Houston, Texas

Mikala Egeblad, PhD
Chair-Elect

Mikala Egeblad, PhD

(2020-2022)

Professor
Cancer Center Program Co-Leader 
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York

Sergei I. Grivennikov, PhD

Sergei I. Grivennikov, PhD

(2020-2023)

Research Scientist II
Cedars-Sinai Medical Center
Los Angeles, California

Xin Lu, PhD

Xin Lu, PhD

(2019-2022)

John M. and Mary Jo Boler Assistant Professor
University of Notre Dame, Department of Biological Sciences, Center for Rare & Neglected Diseases, Harper Cancer Research Institute
Notre Dame, Indiana

Ilaria Malanchi, PhD

Ilaria Malanchi, PhD

(2020-2023)

Senior Group Leader
The Francis Crick Institute
London, United Kingdom

Jeffrey W. Pollard, PhD

Jeffrey W. Pollard, PhD

(2019-2021)

Director, MRC Centre for Reproductive Health
University of Edinburgh, The Queen’s Medical Research Institute
Edinburgh, United Kingdom

Ashani T. Weeraratna, PhD

Ashani T. Weeraratna, PhD

(2020-2022)

E.V. McCollum Chair of Biochemistry and Molecular Biology
Bloomberg Distinguished Professor of Cancer Biology
Co-Program Leader, Cancer Invasion and Metastasis, Sidney Kimmel Cancer Center
Johns Hopkins School of Medicine
Baltimore, Maryland

Alana L. Welm, PhD

Alana L. Welm, PhD

(2019-2022)

Full Professor, Department of Oncological Sciences, University of Utah;
Investigator;
Co-Leader, Cell Response and Regulation Program
Huntsman Cancer Institute
Salt Lake City, Utah

Yves A. DeClerck, MD
Representative of the International Cancer Microenvironment Society (ICMS)

Yves A. DeClerck, MD

(2019-2021)

Professor of Pediatrics, Biochemistry & Molecular Medicine
USC/Children’s Hospital of Los Angeles
Los Angeles, California

Julio A. Aguirre-Ghiso, PhD
Representative of the Metastasis Research Society (MRS)

Julio A. Aguirre-Ghiso, PhD

(2020-2022)

Professor, Departments of Medicine, Otolaryngology and Oncological Sciences;
Research Leader, Metastasis Treatment Center;
Co-Leader, Tisch Cancer Institute at Mount Sinai;
Director, Head and Neck Cancer Basic Research
Icahn School of Medicine at Mount Sinai
New York, New York